Perbedaan Hetzer Medical Indonesia Tbk. dan Saraswanti Indoland Development Tbk.: Hetzer Medical Indonesia Tbk. diperdagangkan di Rp73 (kapitalisasi pasar 109,38 M, volume 24 jam 60,43 jt), sedangkan Saraswanti Indoland Development Tbk. diperdagangkan di Rp113 (kapitalisasi pasar 576,2 M, volume 24 jam 164,77 jt). Perbedaan utamanya: Saraswanti Indoland Development Tbk. jauh lebih besar — sekitar 5,3× kapitalisasi pasar Hetzer Medical Indonesia Tbk., dan Saraswanti Indoland Development Tbk. lebih aktif diperdagangkan (164,77 jt vs 60,43 jt). Mana yang lebih baik tergantung tujuan investasimu.
| MEDS | SWID | |
|---|---|---|
Kapitalisasi Pasar | 109,38 M | 576,2 M |
Volume | 60,43 jt | 164,77 jt |
Lot | 604,35 rb | 1,65 jt |
Perputaran | 4,46 M | 19,28 M |
Harga Rata-rata | 73,8 | 117,01 |
Nilai Transaksi | 4,46 M | 19,28 M |
Harga Ekuilibrium Indikatif | 73 | 113 |
Volume Ekuilibrium Indikatif | 12,68 rb | 11,44 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Selengkapnya di halaman MEDS →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Selengkapnya di halaman SWID →